{"id":"W4386959308","doi":"10.1016/j.jtct.2023.09.014","title":"Continuous Elotuzumab, Pomalidomide, and Dexamethasone Maintenance Following Second Autologous Transplantation for Multiple Myeloma: Results of a Prospective Phase 2 Multicenter Trial","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health; Takeda Pharmaceuticals U.S.A.; Bristol-Myers Squibb; Multiple Myeloma Research Foundation","keywords":"Medicine; Pomalidomide; Multiple myeloma; Maintenance therapy; Dexamethasone; Salvage therapy; Internal medicine; Melphalan; Transplantation; Autologous stem-cell transplantation; Surgery; Progression-free survival; Oncology; Lenalidomide; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00245455,0.001679452,0.002773151,0.0003527571,0.0004835639,0.001801473,0.001291881,0.00132874,0.002299038],"category_scores_gemma":[0.00121936,0.0004311973,0.001754695,0.0006411948,0.001565608,0.001438815,0.0005895172,0.0043689,0.0006172418],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00120059,"about_ca_system_score_gemma":0.001521712,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001173603,"about_ca_topic_score_gemma":0.001970783,"domain_scores_codex":[0.9990594,0.000421528,0.00004329135,0.0001930102,0.00008808497,0.0001947022],"domain_scores_gemma":[0.9985359,0.0003244763,0.0003258134,0.0001867864,0.00006180485,0.0005652867],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9333816,0.01973438,0.003646147,0.0001940242,0.001321327,0.00005933883,0.00009649057,0.0006395117,0.003485879,0.00009933879,0.0008257554,0.0365162],"study_design_scores_gemma":[0.8194584,0.1662113,0.01086458,0.00003353304,0.000741999,0.0001042884,0.00005234973,0.0004517977,0.0009727198,0.0001828707,0.0009016354,0.00002440256],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948644,0.002808096,0.0002613605,0.0002709231,0.0001199589,0.0005562588,0.0003980531,0.00004035124,0.0006805747],"genre_scores_gemma":[0.9940639,0.0014718,0.0007088833,0.0006619553,0.0002680846,0.0006938602,0.001073475,0.00002033249,0.001037691],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002773151,"threshold_uncertainty_score":0.01298106,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02814743779167149,"score_gpt":0.3177173585751594,"score_spread":0.2895699207834879,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}